KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) FCF Margin (2016 - 2025)

Historic FCF Margin for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to 9.74%.

  • Amgen's FCF Margin fell 386900.0% to 9.74% in Q4 2025 from the same period last year, while for Dec 2025 it was 22.04%, marking a year-over-year decrease of 90600.0%. This contributed to the annual value of 22.04% for FY2025, which is 90600.0% down from last year.
  • Latest data reveals that Amgen reported FCF Margin of 9.74% as of Q4 2025, which was down 386900.0% from 44.45% recorded in Q3 2025.
  • Amgen's 5-year FCF Margin high stood at 54.94% for Q2 2023, and its period low was 3.53% during Q4 2023.
  • Its 5-year average for FCF Margin is 28.8%, with a median of 32.05% in 2021.
  • Its FCF Margin has fluctuated over the past 5 years, first surged by 449000bps in 2024, then plummeted by -386900bps in 2025.
  • Amgen's FCF Margin (Quarter) stood at 36.82% in 2021, then fell by -8bps to 33.76% in 2022, then crashed by -90bps to 3.53% in 2023, then surged by 1273bps to 48.43% in 2024, then plummeted by -80bps to 9.74% in 2025.
  • Its last three reported values are 9.74% in Q4 2025, 44.45% for Q3 2025, and 20.82% during Q2 2025.